AI-extracted from the 10-Q filed 2026-08-05 — Q2 2026 (quarter ended June 30, 2026). Every figure is machine-verified against the filing text on SEC EDGAR.
Total revenue rose to $1.60B in Q2 2026 from $1.48B a year earlier, driven by 16% health premium growth to $437M on Medicare Supplement sales and approved rate increases, lifting net income 14% to $288M.
Biggest Revenue Drivers
Life premium$860.8M
American Income, Globe Life's largest life channel, grew life premium; DTC net sales declined amid reduced paid search volume
Health premium$436.9M
Higher premiums from strong growth in Medicare Supplement sales plus approved premium rate increases on individual Medicare Supplement policies
Biggest Revenue Drivers
Total revenue: $1,599.7M
Life premium$860.8M
American Income, Globe Life's largest life channel, grew life premium; DTC net sales declined amid reduced paid search volume
Health premium$436.9M
Higher premiums from strong growth in Medicare Supplement sales plus approved premium rate increases on individual Medicare Supplement policies
Within Health premium
United American$213.0M
Largest health distribution channel at 48% of health premium; net sales up on Medicare Advantage-to-Supplement migration
Net investment income$293.8M+4% YoY
Higher earned yields on fixed maturities, commercial mortgage loans and other long-term investments
Realized gains (losses)$7.1M
Versus a $18.6M loss in the prior-year quarter, aided by $8.5M of other gains
Largest Expense Items
Total policyholder benefits$798.3M
Health policyholder benefits rose to $277.0M from $229.9M, while life benefits fell to $514.0M on improved mortality
Commissions, premium taxes, and non-deferred acquisition costs$173.8M
Higher health commissions of $47.5M and non-deferred acquisition costs on sales growth
Amortization of deferred acquisition costs$120.5M
Life amortization of $104.7M plus health amortization of $15.9M on a growing in-force block
Other operating expense$116.3M
Higher information technology costs ($24.6M) and employee costs; legal costs fell to $3.9M
Margins: Life underwriting margin held at 41% of premium as net policy obligations improved to 35% from 37% on better mortality; health margin slipped to 23% from 24% as United American's mix carries higher policy obligations and group claims experience worsened.
Watch Items from the Filing
Fixed maturities carry $1,675.1M of gross unrealized losses against $311.3M of gains, with $8.2B of fair value in a loss position twelve months or longer.
Securities class action and multiple derivative suits stemming from short-seller reports remain pending; the Company states any loss cannot be reasonably estimated at this time.
Average producing agent count at American Income, the largest life channel, fell 5% to 11,228 on lower retention of new agents.
Unfunded investment fund commitments were $762M plus $354M in fixed maturities and $18M to commercial loan borrowers as of June 30, 2026.
Company repurchased 2.6 million shares for $378 million (average $146.99) in the first half, with $736 million remaining under authorization.
AI-extracted and verified against SEC EDGAR filing text. Not investment advice.
6 transactions in GL reported by 3 members of Congress under the STOCK Act, most recent trade Jul 10, 2025. Reported transactions, not recommendations.
About GLOBE LIFE INC. (GL): stock profile, AI score and financials
GLOBE LIFE INC. (GL) stock profile, AI quality score, and SEC EDGAR financial data, a Financials sector company. 13F Pro's AI-powered ranking engine scores GL at 65.9/100 on a composite quality score built from its SEC filings, placing it at rank #445 of 2,925 stocks — the top 25% of the AI-ranked universe. GL scores in the top quartile across institutional flow (95.3), revenue scale (80.6), profitability (80.3). Based on the latest XBRL financial filings (Q2 2026), GLOBE LIFE INC. reports quarterly revenue of $1.6B, net income of $287.7M, an operating margin of 22.2%. Top institutional holders of GL by reported 13-F value include BlackRock, VANGUARD CAPITAL MANAGEMENT, Invesco Ltd., based on the most recent SEC filings. GL trades on the NYSE exchange and files with the SEC under CIK 320335. 13F Pro's AI research platform runs 10 specialized AI analysts — value, growth, momentum, macro, and activist specialists — that debate GL daily and publish AI-generated analysis with cited SEC sources. The platform aggregates historical XBRL financial facts, 10-Q and 10-K filings, insider Form 4 transactions, and institutional 13-F holdings for GLOBE LIFE INC. directly from SEC EDGAR.